Abortion pill manufacturer asks to join suit that could rewrite US abortion access | US news

The manufacturer of the public version of the main abortion seed asked to join a federal lawsuit on the future of birth control pills, which represents a new step forward in litigation that can re -write us miscarriage access.

The manufacturer, Genbiopro, submitted the court papers on Monday to be invited to the lawsuit on MivePristone, one of the two drugs usually used to abort American drugs. That lawsuit that I brought republican General lawyers Idahoand Missouri and KansasIt seeks to reflect the food and drug management regulations that have greatly expanded to access the birth control pills, such as the provisions that allow service providers He described it through health care.

More than 60 % of American abortion. Last year, tens of thousands of them were presented through a distance health care, including women who live in states with the prohibition of abortion, according to #Count, a research project from the Family Planning Association.

“Despite the vast majority of Americans – including the components of these public lawyers – they support the legal right to abortion, these politicians are still determined to restrict severe access to a critical drug that women in all parts of America depend on,” said Sky Periman, president and executive director of democracy forward, in a statement. Lawyers from the Democratic striker work on the Genbiopro legal team.

Beriman continued: “Their baseless attacks are not only exposed to the availability of Mivipriston, but also threaten the safety of the drug regulation system in our nation.”

The lawsuit is a continuation of a case that arrived at the US Supreme Court last year. It was brought for the first time by the abortion control coalition known as the coalition for volcanic medicine. In the ruling of 9-0, the judges found that the alliance It lacks the legal status to bring the case and Return it to the lower court.

However, Judge Matthew Kuxamerik from the Northern Province in Texas, in January, spent the general lawyers from Idahu, Missouri and Kandas. It can continue in the case for now. Kacsmaryk, which was appointed before Donald TrumpIn the previous version of the case, it issued an order from the court that would completely come out of the MivePristone from the market. This matter was frozen by the Supreme Courts.

under Joe BidenThe Food and Drug Administration (FDA) defended itself against the lawsuit and argued in favor of maintaining the organization of the current drug in the Food and Drug Administration. Under Trump, however, the FDA is expected to leak widely.

Danco Laboratories, which makes MivePristone under the name of the MivePrex brand, is already the defendant in the lawsuit.

More than 100 studiesAnd that were conducted over decades and dozens of countries, found that MivePristone and Misoprostol, the second drug usually used in American abortion operations, secure.

Other states, at the same time, aim to the ability of service providers to dispense with abortion pills across the state lines. Texas filed a civil lawsuit against the New York doctor, who was claimed to have prescribed birth control pills to a woman in Texas, while Louisiana is following a criminal case against the doctor himself. New York, which has a shield law to protect abortion providers working in other states, refused to sign a delivery order for Louisiana.